JESMYN ZANABRIA: Open Payments
NPI 1841930872 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 9 payments from 5 companies in 2025. Trend: 2023 $162 · 2024 $466 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $394 |
| Merck Sharp & Dohme LLC | 3 | $173 |
| ABBVIE INC. | 1 | $95 |
| Shionogi Inc | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: ZERBAXA, Fetroja, PIFELTRO, VOWST.
Industry payments across WA — which companies pay providers there.
